Live Quote · NASDAQMXCTHealthcare· Biotechnology

MaxCyte, Inc.

$1.37▲ 7.03%(+$0.09)
MKT CAP $141.45MNEXT EARNINGS Mar 16, 2027
50%
Bullish
TickerSpark Score
59/100
▌ Mixed
67
Valuation
40
Profitability
10
Growth
80
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MXCT research report →

Analyst Price Target
$4.00+192.0% vs. today

Range $4 – $4

Analyst RatingBuy
4 Buy2 Hold0 Sell

Price Chart

-15.95% · this period
$1.76$1.22$0.68Nov 20May 26Nov 20
52-Week Range63% of range
Low
$0.64
Current
$1.37
High
$1.80